SUMO4 and TPM3

  • Number of citations of the paper that reports this interaction (PMID 16236267)
  • 15
  • Data Source:
  • HPRD (in vivo)

SUMO4

TPM3

Gene Name small ubiquitin-like modifier 4 tropomyosin 3
Image No pdb structure No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 75 interactors: ACADM ACO2 ACTG1 ALDOA ARHGDIA ATP5B CALR CAT CCT2 CCT5 CCT6A CCT7 CLIC1 DNAJA1 DNAJB11 EIF3I ENO1 ENO2 FOS G6PD GAPDH GMPS GNB2L1 GSTP1 HNRNPD HNRNPF HNRNPH1 HNRNPL HSPA1B HSPA5 HSPA8 HSPA9 HSPD1 IDH1 IDH3A IMPDH2 JUN LDHB LMNA LMNB1 MRPS22 NFKBIA NR3C1 PA2G4 PAFAH1B3 PDIA3 PDIA6 PGK1 PHB PHGDH PITHD1 PPA1 PRDX2 PRDX3 PRDX4 PRDX6 PRPS1 PSMC2 RPSA SF3B4 SPINT2 STAT1 STAT3 STIP1 STOML2 STRAP TFAP2A TOP2A TPM3 TUBA1C TXNL1 UBE2V1 VCP VDAC1 ZPR1 41 interactors: ACTA1 ACTB BLOC1S6 C1orf216 CCDC102B CCDC114 CCDC146 CCHCR1 CNN1 FAM9C FBXO5 HDDC3 HSF2 IFIT3 IKBIP KCNE1 KIFC3 KXD1 LCA5L LURAP1 MAD1L1 MAGEA11 NEK2 OIP5 PBX3 S100A2 S100A4 SMAD3 SUMO4 SYCE1 TFPT THAP1 TLK1 TMOD1 TMOD2 TNNT1 TRAP1 TRIM27 TRIP6 VPS52 WASH3P
Entrez ID 387082 7170
HPRD ID 10584 01840
Ensembl ID ENSG00000177688 ENSG00000143549
Uniprot IDs Q6EEV6 B4DQ80 P06753 Q5VU58 Q5VU63 Q8TCG3
PDB IDs
Enriched GO Terms of Interacting Partners?
Tagcloud ?
accumulating  behcet  ccr1  ccr3  ccr6  cd40  ctla4  elucidating  fcrl3  han  helpful  hopefully  il17  il23r  immunoregulatory  irf5  l2  mcp  multisystemic  mystery  opn  predisposition  profound  ptpn22  regimes  stat4  tgfbr3  tgrbr3  ubac2 
aacr  accelerated  advancements  ago  approved  developments  discov  encodes  fda  fusions  harboring  next  ntrk1  oncd  oncogene  oncogenic  oncology  originally  precision  rationale  rearrangements  revisit  scientific  throughput  transforming  trk  trka  trkb  trkc 
Tagcloud (Difference) ?
accumulating  behcet  ccr1  ccr3  ccr6  cd40  ctla4  elucidating  fcrl3  han  helpful  hopefully  il17  il23r  immunoregulatory  irf5  l2  mcp  multisystemic  mystery  opn  predisposition  profound  ptpn22  regimes  stat4  tgfbr3  tgrbr3  ubac2 
aacr  accelerated  advancements  ago  approved  developments  discov  encodes  fda  fusions  harboring  next  ntrk1  oncd  oncogene  oncogenic  oncology  originally  precision  rationale  rearrangements  revisit  scientific  throughput  transforming  trk  trka  trkb  trkc 
Tagcloud (Intersection) ?